期刊
FUTURE SCIENCE OA
卷 2, 期 1, 页码 -出版社
FUTURE SCI LTD
DOI: 10.4155/fso.15.84
关键词
adenocarcinoma; AKT; HIF-1; HNSCC; hypoxia; NSCLC; squamous cell carcinoma
Background: Hypoxia is a negative prognostic factor and this study investigated the relationship between hypoxia, hypoxia inducible factor 1 (HIF-1) and AKT signaling in head and neck squamous cell carcinoma (HNSCC) and non-small-cell lung cancer (NSCLC). Results/methodology: pAKT was induced by hypoxia (0.5% O-2) in a part of HNSCC (3/4) and squamous (2/3) and adenocarcinoma (1/3) NSCLS lines. AKT-inhibitor MK-2206 reduced hypoxic HIF-1 signaling in most HNSCC cell lines. This reduction did not correlate with hypoxic induction of pAKT or with sensitivity to MK-2206 under hypoxia. Patient biopsies revealed a hypoxia-induced expression pattern of pAKT in HNSCC (n = 16), which was not observed in squamous cell (n = 34) or adenocarcinoma (n = 41) NSCLC. Conclusion: The interaction between hypoxia, HIF-1 and AKT signaling varies between tumor types and histologies, which could significantly affect response to targeted therapies. Lay abstract: Hypoxia is the result of an imbalance between oxygen delivery and oxygen consumption, and hypoxic areas are a common feature in solid tumors, including head and neck and lung cancer. Hypoxia activates various signaling pathways that enhance the survival of tumor cells (e.g., HIF-1 and AKT) and is, therefore, an inherent negative factor for outcome. In this study, we show that the interaction between hypoxia and these pathways varies widely between tumor types and histologies. This variation could significantly affect response to treatments targeting hypoxia or these signaling pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据